Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viatris Inc. - Common Stock (NQ:VTRS)

12.86 +0.02 (+0.16%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viatris Inc. - Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
News headline image
VTRS Stock Alert: What to Know as Viatris Appoints New CEO ↗
Viatris (VTRS) stock is in the news Monday after the healthcare company announced Scott Smith is taking over as its next CEO. 
Via InvestorPlace
News headline image
BioAtla Announces Change in Executive Leadership
From BioAtla, Inc.
Via GlobeNewswire
News headline image
2 Dividend Stocks to Buy at a Discounted Price In 2023 ↗
Their shares are ripe for getting while the getting is good. 
Via The Motley Fool
News headline image
Nasdaq, S&P 500 Futures Rebound In New Trading Week But Rising Bond Yields Remain A Risk ↗
US stocks are coming off a lackluster week and early indications suggest a reversal in sentiment in the new trading week. While rising bond yields could be a cause of concern, the recent weakness could... 
Via Benzinga
News headline image
Earnings Preview: Viatris ↗
 
Via Benzinga
News headline image
BMO Downgrades Viatris As Its Looks For More Visibility On Next Phase ↗
 
Via Benzinga
News headline image
Where Viatris Stands With Analysts ↗
 
Via Benzinga
News headline image
Stock Analysis: Viatris ↗
In the past year, Viatris’s share price dropped by $2.76, or about 19%. 
Via Talk Markets
News headline image
Earnings Scheduled For February 27, 2023 ↗
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million. 
Via Benzinga
Golden Cross Appears Before Viatris Investors ↗
 
Via Benzinga
News headline image
2 Superb Dividend Stocks to Buy Before the Next Bull Market ↗
There might not be an opportunity to get them for much cheaper than now. 
Via The Motley Fool
News headline image
3 Dirt-Cheap Stocks to Buy Sooner Rather Than Later ↗
These pharmaceutical stocks probably won't stay so attractively valued for too much longer. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2023 ↗
 
Via Benzinga
News headline image
NVIDIA To Rally Around Over 30%? Here Are 10 Other Analyst Forecasts For Friday ↗
Keybanc boosted the price target for NVIDIA Corporation (NASDAQ: NVDA) from $220 to $280. Keybanc analyst John Vinh maintained an Overweight rating on the stock. NVIDIA shares fell 1.7% to $216.22 in... 
Via Benzinga
News headline image
These Are 3 of the Nasdaq's Cheapest Dividend Stocks ↗
These stocks can be good options whether you value dividends or growth. 
Via The Motley Fool
News headline image
3 Healthcare Stocks That Are Too Cheap to Ignore ↗
Pay attention when stocks have these kinds of low valuations. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023 ↗
 
Via Benzinga
News headline image
2 Superb Dividend Stocks to Buy Today and Hold Forever ↗
These two companies have long runways for growth and decent yields today. 
Via The Motley Fool
News headline image
3 Dividend Stocks That Are Ridiculously Cheap Right Now ↗
Their valuations are low and their yields are high. 
Via The Motley Fool
News headline image
Could This New Drug Launch Be a Hit for Viatris? ↗
Viatris and Kindeva Drug Delivery could soon launch a generic version of AstraZeneca's Symbicort. 
Via The Motley Fool
News headline image
Is Now the Time to Buy 3 of the S&P 500's Cheapest Stocks? ↗
All of these stocks are trading at less than 7 times their future profits. 
Via The Motley Fool
News headline image
Why These 7 Healthcare Stocks Could Soar in 2023 ↗
These healthcare stocks to buy are trading at a hefty discount and are poised to deliver robust returns in 2023. 
Via InvestorPlace
News headline image
Could This Drug News Give a Lift to Eli Lilly Stock? ↗
In November, Eli Lilly received positive news from the U.S. Food and Drug Administration. 
Via The Motley Fool
News headline image
1 Passive Income Stock to Buy While It's Cheap and 1 to Avoid ↗
Both businesses are well-suited for producing passive income, but only one has the balance sheet and future prospects to make it work. 
Via The Motley Fool
News headline image
3 High-Yielding Dividend Stocks That Could See Hikes in January ↗
These stocks all pay more than 3% in dividends. 
Via The Motley Fool
News headline image
'Sell The Darlings, Own The Dogs': Why It May Soon Be Time To Buy Tesla, Meta And Other Worst-Performing Stocks Of 2022 ↗
Several popular seasonal trading strategies are associated with the closing weeks and opening weeks of the calendar year. 
Via Benzinga
News headline image
The 7 Best Crypto and Stocks to Buy as Christmas Gifts This Year ↗
These stocks to buy as Christmas gifts provide a number of reasons for investors to rejoice this holiday season. 
Via InvestorPlace
News headline image
2 Mammoth Stocks With Dividends to Buy Before 2022 Ends ↗
Blue chip healthcare stocks Johnson & Johnson and Cigna are always in season. 
Via The Motley Fool
News headline image
The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond ↗
These seven hottest healthcare stocks have strong growth catalysts that could send each of them higher over the next few years. 
Via InvestorPlace
News headline image
Want $3,000 in Dividend Income Next Year? Invest $50,000 in These 2 Stocks ↗
These stocks have dividend yields exceeding 4%. 
Via The Motley Fool
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.